Long Wharf Investors, Inc. - Valeant Pharmaceuticals ownership

Back to all holdings Add to watchlist

Valeant Pharmaceuticals's ticker is VRX and the CUSIP is 91911X104. A total of 1 filers reported holding Valeant Pharmaceuticals in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Links
Filings
External links
Quarter-by-quarter ownership
Long Wharf Investors, Inc. ownership history of Valeant Pharmaceuticals
ValueSharesWeighting
Q2 2014$657,000
-1.8%
5,211
+2.7%
0.52%
-9.9%
Q1 2014$669,000
-12.2%
5,076
-21.8%
0.57%
-17.0%
Q4 2013$762,000
-8.1%
6,488
-18.4%
0.69%
-12.7%
Q3 2013$829,000
-1.7%
7,948
-18.9%
0.79%
-4.7%
Q2 2013$843,000–9,795–0.83%–
 Download
Other shareholders

There were no reported owners of Valeant Pharmaceuticals in Q2 2014.

NameSharesValueWeighting ↓
View complete list of Valeant Pharmaceuticals shareholders